European urology focus
A Practical Guide for the Management of Toxicities Associated with Belzutifan
Abstract
Belzutifan offers a significant therapeutic advance for von Hippel-Lindau-associated and advanced renal cell carcinoma but is associated with notable toxicities, particularly anemia and hypoxia. Effective management requires vigilant monitoring, timely interventions, and dose adjustments.
Source and rights
Published by European urology focus, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2025
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- European urology focus
- PubMed
- 40268638
- Added to Prognia
- 22 July 2026
More in urology
- Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in childrenEuropean Association of Urology (EAU) and the European Society for Paediatric Urology (ESPU) · 2026
- Fertility Restoration After Vasectomy: AUA Guideline (2026) Part II.American Urological Association · 2026
